We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$9.44B
AUM Growth
+$1.08B
Cap. Flow
+$1.04B
Cap. Flow %
11.03%
Top 10 Hldgs %
56.7%
Holding
92
New
16
Increased
26
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$112M
2
ZM icon
Zoom
ZM
+$83.8M
3
GIL icon
Gildan
GIL
+$73.7M
4
EPC icon
Edgewell Personal Care
EPC
+$60.3M
5
AMCR icon
Amcor
AMCR
+$56.1M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$298M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$196M
3
FLR icon
Fluor
FLR
+$164M
4
ROIV icon
Roivant Sciences
ROIV
+$103M
5
VST icon
Vistra
VST
+$80.9M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Utilities 19.69%
3 Industrials 9.76%
4 Energy 6.79%
5 Communication Services 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVGW
51
DELISTED
Calavo Growers
CVGW
$36.5M 0.39%
+1,416,662
New +$35.5M
CRI icon
52
Carter's
CRI
$1.41B
$36.4M 0.39%
1,018,853
+558,853
+121% +$20.3M
VISN
53
Vistance Networks Inc
VISN
$2.7B
$36.4M 0.39%
+2,000,000
New +$36.5M
MATV icon
54
Mativ Holdings
MATV
$439M
$34.6M 0.37%
3,982,442
– –
LILA icon
55
Liberty Latin America Class A
LILA
$1.46B
$32.4M 0.34%
5,520,000
+2,659,808
+93% +$14M
TSAT icon
56
Telesat
TSAT
$576M
$30.5M 0.32%
843,781
– –
ABUS icon
57
Arbutus Biopharma
ABUS
$871M
$29.8M 0.32%
6,626,389
+5,051,013
+321% +$22.1M
PRLB icon
58
Protolabs
PRLB
$1.85B
$27.7M 0.29%
486,400
-636,938
-57% -$37M
COMP icon
59
Compass
COMP
$8.89B
$27.4M 0.29%
3,746,848
-3,253,152
-46% -$34.2M
BMRN icon
60
BioMarin Pharmaceuticals
BMRN
$11.5B
$24.9M 0.26%
+440,560
New +$25.7M
HRTX icon
61
Heron Therapeutics
HRTX
$89.7M
$24M 0.25%
30,046,828
– –
AVO icon
62
Mission Produce
AVO
$1.15B
$23.8M 0.25%
+1,726,447
New +$23M
VG
63
Venture Global Inc
VG
$35.8B
$23.6M 0.25%
+1,500,000
New +$16.1M
XPER icon
64
Xperi
XPER
$353M
$23.2M 0.25%
4,143,744
– –
TH icon
65
Target Hospitality
TH
$1.63B
$20.3M 0.22%
2,189,456
– –
INDV icon
66
Indivior Pharmaceuticals
INDV
$4.73B
$20.2M 0.21%
662,515
+163,988
+33% +$5.42M
ACHC icon
67
Acadia Healthcare
ACHC
$3.18B
$19.9M 0.21%
850,000
– –
ADMA icon
68
ADMA Biologics
ADMA
$2.03B
$16.3M 0.17%
+1,809,408
New +$28.6M
DNOW icon
69
DNOW Inc
DNOW
$2.55B
$15.1M 0.16%
+1,267,527
New +$17.2M
SEG
70
Seaport Entertainment Group
SEG
$335M
$12.2M 0.13%
568,530
– –
CPRI icon
71
Capri Holdings
CPRI
$1.83B
$11.9M 0.13%
675,000
– –
ARDX icon
72
Ardelyx
ARDX
$1.28B
$11.1M 0.12%
+1,860,896
New +$12.3M
EMBC icon
73
Embecta
EMBC
$201M
$9.17M 0.1%
1,037,416
– –
MNKD icon
74
MannKind Corp
MNKD
$1.25B
$8.87M 0.09%
3,620,413
-3,856,082
-52% -$17.2M
AERO
75
Grupo Aeromexico SAB de CV
AERO
$2.27B
$6.54M 0.07%
+467,129
New +$8.48M
1 2
3
4

Similar funds

SCM
SCS Capital Management Boston, Massachusetts $9.44B AUM 18.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $9.42B AUM 33.59% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2026 Portfolio in Review

As of Q1 2026, Rubric Capital Management (New York) held 92 positions worth $9.44B, up 13% from $8.36B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Rubric Capital Management (New York) deployed $1.04B of net new capital in Q1 2026, opening 16 new positions and adding to 26 existing holdings. Its largest new stake was Zoom: 1,001,006 shares worth $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was FTAI Aviation, an estimated $298M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2026 buy was Zoom: 1,001,006 shares worth $80.5M.
  • Rubric Capital Management (New York) added most to Viatris in Q1 2026, an estimated $112M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $298M.
  • Rubric Capital Management (New York) fully exited Fluor in Q1 2026, selling an estimated $164M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 57% of its $9.44B portfolio in Q1 2026.
  • Rubric Capital Management (New York) opened 16 new positions and closed 9 in Q1 2026.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $9.44B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.